Literature DB >> 22088806

Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China.

Dianliang Wang1, Min Su, Dongping Tian, Shuang Liang, Jing Zhang.   

Abstract

PURPOSE: To study the causes of esophageal cancer in Chaoshan and Taihang areas.
METHODS: By using gel-based DNA microarray genotyping method, four cancer-related polymorphisms including CYP1A1 m2, CYP1A1 m4, CYP2E1 Pst I and CYP2E1 Rsa I were studied with 565 (CYP1A1) or 482 (CYP2E1) cases and 468 (CYP1A1) or 466 (CYP2E1) controls.
RESULTS: For CYP1A1 m2, the mutant allele frequencies were 21.3% (Chaoshan) and 19.6% (Taihang), and OR for AG versus AA genotype (Chaoshan) was 1.855 (95% CI [1.227-2.805]). For CYP1A1 m4, no mutant allele was detectable. For CYP2E1 Pst I, the mutant allele frequencies were 27.3% (Chaoshan) and 29.4% (Taihang), and OR for GG versus CC genotype (Taihang) was 3.263 (95% CI [1.059-10.052]). For CYP2E1 Rsa I, the mutant allele frequencies were 27.3% (Chaoshan) and 29.6% (Taihang), and OR for CC versus TT genotype (Taihang) was 3.167 (95% CI [1.026-9.776]).
CONCLUSION: The results suggest that AG genotype of CYP1A1 in Chaoshan area and GG (CC) genotype of CYP2E1 in Taihang area are significantly associated with esophageal cancer susceptibility.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088806     DOI: 10.1016/j.canep.2011.10.008

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  9 in total

1.  Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.

Authors:  Rim Khlifi; Ghada Ben Salah; Amine Chakroun; Amel Hamza-Chaffai; Ahmed Rebai
Journal:  Mol Biol Rep       Date:  2014-06-17       Impact factor: 2.316

2.  Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.

Authors:  Feng-Feng Gong; Shan-Shan Lu; Cai-Yun Hu; Zhen-Zhong Qian; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  Tumour Biol       Date:  2014-07-22

Review 3.  Epidemiological studies of esophageal cancer in the era of genome-wide association studies.

Authors:  An-Hui Wang; Yuan Liu; Bo Wang; Yi-Xuan He; Ye-Xian Fang; Yong-Ping Yan
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis.

Authors:  Fang-Fang Shen; Fu-You Zhou; Qi-Si Xue; Ying Pan; Lu Zheng; Hua Zhang; Li-Dong Wang; Hou-Feng Zheng
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

5.  Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.

Authors:  Hui Zheng; Yun Zhao
Journal:  Eur J Med Res       Date:  2015-03-30       Impact factor: 2.175

6.  Salivary microRNAs as promising biomarkers for detection of esophageal cancer.

Authors:  Zijun Xie; Gang Chen; Xuchao Zhang; Dongfeng Li; Jian Huang; Cuiqin Yang; Pingyong Zhang; Yuxuan Qin; Yifan Duan; Bo Gong; Zijun Li
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

7.  Association of CHRNA5-A3-B4 variation with esophageal squamous cell carcinoma risk and smoking behaviors in a Chinese population.

Authors:  Yang Wang; Haijian Wu; Qiji Liu; Cuihong Wang; Lei Fu; Han Wang; Wenjie Zhu; Weijiang Fu; Yajuan Lv; Shikun Wang; Likuan Hu
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

8.  Cytochrome P450 1A1 gene polymorphisms and digestive tract cancer susceptibility: a meta-analysis.

Authors:  Anjing Ren; Tingting Qin; Qianqian Wang; Haina Du; Donghua Zhong; Yibing Hua; Lingjun Zhu
Journal:  J Cell Mol Med       Date:  2016-04-06       Impact factor: 5.310

9.  Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma.

Authors:  Hai Zhang; Haiyan Li; Huanxin Yu
Journal:  Cancer Cell Int       Date:  2018-05-01       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.